Sreelakshmi24’s Blog

where life is all about learning

Posts Tagged ‘chennai

Aloka SSD 500 to be rolled out in the first phase from Trivitron’s manufacturing facility in Chennai

leave a comment »

Aloka Trivitron Medical Technologies Pvt Ltd announced the commencement of the production of Aloka SSD 500, portable Black and White ultrasound scanner. The company is a medical equipment manufacturing company formed under the joint venture between Aloka Japan and Trivitron Healthcare. This is the first production from the manufacturing facility of the company located at Poonamallee, Chennai, which aims to roll out world class medical equipments at most effective costs to national and international customers.

Aloka SSD 500 is a multi-purpose diagnostic ultrasound system providing excellent image quality with comprehensive function in a truly portable body. Aloka SSD 500 is a world premier portable model now being produced in India with international quality standards.

Speaking on the occasion, Dr. G.S.K. Velu, Managing Director, Trivitron said, “We are proud to commence the first production of Portable Black and White ultrasound scanner Aloka SSD 500 from our manufacturing facility at Chennai. The aim of the Aloka, Trivitron JV is to offer products of high quality suited to developing countries needs on a most cost effective basis. Apart from meeting the needs of the Indian Market, the products manufactured by the JV will be exported to several developing/developed countries across the world.”

The manufacturing facility at Chennai will adhere to all international standards such as ISO 9000-2001, ISO 13485 for medical product manufacturing and will also be compliant with requirements for CE, US FDA and Japan MITI certifications.

An array of indigenous products from electronic equipment to consumables will be introduced under PRIDE SERIES.

The core vision of Trivitron Healthcare is to bring world-class medical technology within the reach of medical professionals all over the world. It also aims to set up advanced facilities in joint collaboration for manufacture of Laboratory reagents for Routine and Special Diagnostics testing in JV with Bio-systems, Spain, Operation Theatre Lights, a JV with Brandon Medical, U.K.


iSOFT wins US $ 2.78 million deal with Healthscope

leave a comment »

iSOFT, an IBA Health Group company, yesterday announced an agreement with leading Australian private hospital provider Healthscope Limited valued at US $ 2.78 million over three years.

The agreement to implement its iSOFT’s software at 38 Healthscope hospitals is in addition to a US $ 9.27 million agreement in December 2007 for software licences and support services over seven years. The initial agreement included pilot implementations of iSOFT’s web-based patient administration solution at two hospitals. Following the success of these pilots, implementation will start shortly at Healthscope’s remaining hospitals, including Knox Private Hospital in Victoria, Allamanda Private Hospital in Queensland and Mount Hospital in Western Australia.

The implementation services covered under the latest agreement include:

  • project management
  • software installation
  • system configuration
  • training
  • migrating medical records and data from a range of legacy systems

`Dougall McBurnie, Healthscope’s Group Chief Information Officer said: “Given the marked improvements in feature and function from iSOFT’s web-based patient administration solution experienced at the two pilot installations, we have elected to roll-out the solution to all of our hospitals, thus standardising our data sets, configurations and business processes.” He further added, “The ease of implementation of a common group-wide solution and smooth transition to a modern solution with minimal disruption for staff is a huge bonus.

Healthscope, one of Australia’s largest private healthcare operators, owns or manages medical/surgical, rehabilitation and psychiatric hospitals. It also operates a leading pathology business with facilities in Australia, New Zealand, Singapore and Malaysia.

iSOFT, an IBA Health Group company, is one of the world’s largest providers of healthcare IT solutions. It designs, builds and delivers industry-leading software systems that serve the entire health sector. iSOFT’s capacity to embrace change and keep abreast of emerging new directions in healthcare allows its customers to explore the exciting potential of new technologies while securing their existing investments. Today, over 13,000 provider organizations in 35 countries across five continents use iSOFT solutions to manage patient information and drive improvements in core processes. Its solutions are a catalyst for change, increasing efficiencies and providing direct benefits to all stakeholders across the whole spectrum of care. iSOFT’s business is driven by the collective talent, experience and commitment of over 4,000 specialists around the globe. iSOFT Global Development Centres of Excellence in Chennai and Bangalore contribute strategically to this international footprint.

For further details, please contact:

Ramesh Karajgikar

iSOFT – An IBA Health Group Company

Mobile: +91 (0) 97910 35005

Email: ramesh.karagikar@isoftplc.com

Zylog to launch Recycle Accelerator to track and recycle e-waste

leave a comment »

The ever increasing demands for consumer electronics world over, and limited supply of copper, lead, and other metals demand reusable resources. Proper handling of hazardous electronic waste is already a mounting concern for rapidly developing economies. Citing this global demand and a scalable business opportunity Zylog Systems Limited (ZSL), a leading IT solution provider from Chennai has developed an innovative IT based platform for e-waste management – ‘Recycle accelerator’.

Recycle Accelerator provides sustainable solutions in e-waste management. It enables companies and countries to reutilize reclaimed materials from obsolete, unwanted, and defective products. The platform connects Recyclers, Collectors, Government, and Manufacturers to companies that can reclaim materials for reuse. It creates opportunities to integrated networks that will enable business transactions to occur, enabling collectors to transfer data and goods to recyclers, and for recyclers to locate appropriate downstream buyers to reuse materials. As a result, materials from obsolete product can be reclaimed and reused at lower cost than mining and refining natural elements from mountains in distant countries. Collectors gather these materials from end-users/ consumers.

According to Mr.Ananth Chaganty, Sr. Vice President, Enterprise Solution, ZSL “Zylog’s solution caters to the entire supply chain and can also be customised for entrepreneurs who want to establish a small business as a collector. It can also be used by individuals who want to participate in the part-time activity of collection for profit or to save the environment.” The platform designed as “The Limited Edition” is for individual use and the more sophisticated version which is designed for entrepreneurs and small collection businesses is the Complete Collector Edition. Both versions of the Collector Applications allow easy management of inventory, and direct output to participating recyclers.

There are some software applications on the market that address portions of the business requirements for individual recyclers. However, Recycle Accelerator is the first platform to address and integrate the needs of all participants in the recycling process. The platform allows competitive smaller software applications to connect to the overall network for the benefit of all integrated participants. ZSL believes that the best solution for our environment requires cooperation, communication, and collaborative integration. Therefore, Recycle Accelerator is designed to provide capabilities that did not previously exist for managing the recycling process, supports integration with the smaller customized applications, and provides a comprehensive approach for sustainability.

Globally the revenue for e-waste recycling is set to touch $11 billion in 2009. ZSL has been studying the Recycling and Sustainability Solution since August 2007 and has tied up with national service alliance (NSA) to create the solution. According, Mr. John Mehrmann, VP, Business Development, ZSL, “the company is currently targeting at $70 billion US market where after sales service is far mature than other countries”.
The governments in the US federal severely enact strictures to curb careless disposal of hazardous waste
.

Mr. Mehrmann also pointed out India is experiencing a phenomenal growth rate in consumer electronics, computers, and the proliferation of mobile communication devices. If the society in India encourages immediate government intervention, and the implementation of tracking and controls, India can implement efficient processes for managing e-waste, educating consumers, and avoiding the catastrophe before it occurs. It is a rare chance to look at the rest of the world and be proactive in avoiding a problem, just like the RoHS legislation that restricts strict use of certain hazardous substances in electrical and electronic products.

The target market for Recycle Accelerator begins with the CE Industry, and is designed to expand into other industries very rapidly. The architecture encompasses common business practices with a flexible structure to accommodate a variety of products, parts, and materials. Even though there is nothing else like this in the market, ZSL has committed to make Recycle Accelerator an affordable low cost application, because every business should be empowered to help our environment. Recycle Accelerator offers several different packages with corresponding prices. Recycle Accelerator contains an application for recyclers, and options for customized enhancements to support the individual needs of large scale recyclers. Recycle Accelerator also features unique applications for Collectors, sole-proprietors, and business-to-business online services. As information is stored and shared between partners on the integrated platform, there are services with corresponding prices for manufacturers, call centres, and government agencies. Pricing is based on the application and features selected by the customer. Since Recycle Accelerator is designed for to support continuous enhancements, prices and available features are also subject to change.

For further details visit http://www.recycleaccelerator.com

Another major source of stem cells – menstrual blood

leave a comment »

Stem cells are one of the most fascinating areas of biology today. But like many growing fields of scientific inquiry, research on stem cells raises scientific questions as quickly as it generates new discoveries.

In India, menstruation blood has been considered as dirty and polluting. There have been a lot of myths, taboos and various practices related to menstruation. In olden times, the lady would be made to sit in some corner, wear only particular clothes, use a separate set of vessels for eating and drinking, and she was not allowed to cook. Other members in the family were not to even go near her, let alone touch her!!! At the end of the period, she would ‘cleanse’ herself by taking a hair bath.

Thankfully, while in some of the homes in rural India these restrictions might still be prevalent; in urban homes these rules seem to have lost effect. However, menstrual blood is still today considered sanitary waste. Yet recent findings have revealed menstrual blood to be a rich and easily accessible source of adult stem cells.

LifeCell is the first and the largest private cord blood stem cell bank and stem cell solutions provider in India which facilitates the cryogenic preservation of umbilical cord blood stem cells at its central facility in Chennai, India. They have been doing research on menstrual blood as a source of stem cells. Here is what Dr. Ajit Kumar, Chief Scientific Officer, LifeCell International has to say:

A woman’s role in society and the family is constantly changing. She dons the role of a daughter, sister, wife, mother, an entrepreneur, a working professional, a friend and much more with élan. The master stem cell or the zygote, wherein human life begins, is created when a woman’s egg is fertilized by her partner’s sperm. Shortly thereafter, this master stem cell begins to multiply into hundreds of millions of cells, including a large number of other stem cells, as the embryo develops during the early stages of pregnancy. The less specialized stem cells give rise to more specialized cell types and the process continues throughout pregnancy leading to the formation of all the cell types within the human body such as skin, muscle, nerve, bone, etc. Following birth and throughout adult life, our bodies continue to produce stem cells that serve as a vital source for regeneration and repair throughout our lifetime.

While the concept of stem cells becomes intuitive if one considers the development of complex organisms such as humans from a single cell such as the zygote and also the constant requirements for repair and replenishment of cells, it is only within the last fifty years that stem cells have been recognized for their therapeutic value. It is these therapeutic applications that have become the primary focus of studies by researchers and scientists from around the world. Since the very first bone marrow transplant in the 1950’s, to the 1980’s and ’90’s, when more than 16,000 stem cell transplants were performed to treat leukemia and immune system diseases, research into regenerative cellular therapies for a wide range of human diseases has rapidly advanced. Most recently, medical researchers have discovered adult stem cells in the endometrial lining of the uterus.

Another path breaking discovery in this area is that menstrual blood itself is a rich source of stem cells and serves as a potential source for promising regenerative therapies to treat heart disease, diabetes, neurological disorders like spinal cord injury, Parkinson’s and Alzheimer’s diseases, in addition to cosmeceutical applications such as anti-aging therapies, to name a few. In simple terms potentially life-saving stem cells are found naturally in menstrual blood.

The Menstrual stem cell comes from the uterine lining (endometrium), which is shed as part of a woman’s menstrual period. These menstrual stem cells are unique because they have many properties and characteristics similar to both bone marrow and embryonic stem cells.

Until now, menstrual blood has been discarded as unsanitary waste. However, as recent research has shown menstrual fluid contains self-renewing stem cells that can be easily collected, processed and cryo-preserved for potential cellular therapies that may emerge in the future. They multiply rapidly and can differentiate into many other types of cells such as neural, cardiac, bone, fat, cartilage and possibly others; demonstrating great potential for cell therapy. Preliminary research suggests that in addition to possible use by the donor, these stem cells may also be used to benefit other family members who are genetically related to the donor, such as perhaps a parent, sibling or child.

More information on stem cells is available on www.lifecellinternational.com

Written by sreelakshmi

6 January, 2009 at 7:32 am